HuLuc63
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HuLuc63, covering 2009-09-23 to 2009-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma [Phase 1]